Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

EFung Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 40
Average round size
info
The average size of a deal this fund participated in
$46M
Portfolio companies 36
Rounds per year 1.48
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 2
Key employees 4
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
Summary

In 1996 was created EFung Capital, which is appeared as VC. The company was established in Asia in China. The main department of described VC is located in the Shenzhen.

Speaking about the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. This EFung Capital works on 14 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2001.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the EFung Capital, startups are often financed by InterWest Partners, Shenzhen Capital Group, Quan Capital. The meaningful sponsors for the fund in investment in the same round are Panacea Venture, YuanMing Capital, Viventures. In the next rounds fund is usually obtained by YuanMing Capital, State Development & Investment Corporation (SDIC), RMB Funds.

We also calculated 4 valuable employees in our database.

The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Biopharma, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Centrexion, Elicio Therapeutics, Resverlogix.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of EFung Capital:
Typical Co-investors
EFung Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after EFung Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
APICIL Group Caluire-et-cuire, France, Rhone-Alpes
Bluebird Bio Cambridge, Massachusetts, United States
BUYOVERCHAT TECHNOLOGIES LIMITED Lagos, Lagos, Nigeria
GCC Investments LLC Massachusetts, United States, Wellesley
Gongyinglian Chanye Fazhan Jijin China, Henan, Henan
Guangdong Hengjian Venture Capital China, Guangdong Province, Huizhou
Hightower New York, New York, United States
Paradiso Ventures -
QD Ventures Castel, Guernsey, Guernsey
S5 Partners Japan, Tokyo
SEA Ventures Pennsylvania, Pittsburgh, United States
Seewo College China, Guangdong, Guangzhou
Shanghai Yongquan Yixin Investment Development Center China, Shanghai
Sunflower Development Group -
The Yoshida Group Oregon, Portland, United States
Venture-Net Partners -
WaterEquity Kansas City, Missouri, United States
Wishcompany Seoul, Seoul-t'ukpyolsi, South Korea
Zhejiang Merit Interactive Network Technology China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

IASO Biotherapeutics

Biotechnology
Pharmaceutical
$77M17 Jan 2023 Xuanwu District, Jiangsu, China

Raynovent

Biotechnology
$57M05 Jan 2023 Guangzhou, Guangdong, China

JGene Biotechnology

Biotechnology
Genetics
Health Care
Life Science
03 Jan 2023 Shenzhen, Guangdong, China

Maijing Gene

Biotechnology
Genetics
Health Care
29 Dec 2022 Yuexiu District, Guangdong Province, China

JSD

Health Care
Medical Device
Robotics
27 May 2022 Chengdu, Sichuan, China

CellOrigin Biotech

Biotechnology
$15M29 Mar 2022 Hangzhou, Zhejiang, China

JGene Biotechnology

Biotechnology
Genetics
Health Care
Life Science
21 Feb 2022 Shenzhen, Guangdong, China

West Lake Omi

13 Jan 2022 Otsu, Shiga Prefecture, Japan

Atom Bioscience & Pharmaceutical

Drug Discovery
Health Care
$45M05 Jan 2022 Zhenjiang, Guangdong Province, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent EFung Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: